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ABSTRACT
Canonical microRNA biogenesis requires the
Microprocessor components, Drosha and DGCR8,
to generate precursor-miRNA, and Dicer to form
mature miRNA. The Microprocessor is not required
for processing of some miRNAs, including mirtrons,
in which spliceosome-excised introns are direct
Dicer substrates. In this study, we examine the pro-
cessing of putative human mirtrons and demon-
strate that although some are splicing-dependent,
as expected, the predicted mirtrons, miR-1225 and
miR-1228, are produced in the absence of splicing.
Remarkably, knockout cell lines and knockdown ex-
periments demonstrated that biogenesis of these
splicing-independent mirtron-like miRNAs, termed
‘simtrons’, does not require the canonical miRNA
biogenesis components, DGCR8, Dicer, Exportin-5
or Argonaute 2. However, simtron biogenesis was
reduced by expression of a dominant negative
form of Drosha. Simtrons are bound by Drosha
and processed in vitro in a Drosha-dependent
manner. Both simtrons and mirtrons function in
silencing of target transcripts and are found in the
RISC complex as demonstrated by their interaction
with Argonaute proteins. These findings reveal a
non-canonical miRNA biogenesis pathway that can
produce functional regulatory RNAs.
INTRODUCTION
MicroRNAs (miRNAs) are small non-coding RNAs that
regulate gene expression by direct base-pairing with target
mRNAs (1–3). Canonical miRNAs in animals are
transcribed as primary miRNAs (pri-miRNAs) and sub-
sequently cleaved by the Microprocessor complex,
comprised of the RNase III enzyme Drosha (4–6) and
the double-stranded RNA (dsRNA)-binding protein,
DGCR8/Pasha (4,5,7–9) to yield a pre-miRNA that is
then exported to the cytoplasm by Exportin-5 (XPO5)
(10–12). In the cytoplasm, pre-miRNA is processed
into a  21–23-nt mature miRNA duplex by the RNAse
III enzyme, Dicer (13–17). One strand of the mature
miRNA duplex is preferentially loaded into the
RNA-induced silencing complex (RISC) with members
of the Argonaute family of proteins, producing a function-
al complex for targeting mRNA via direct base pairing
(18–20). The resulting miRNA/mRNA hybrids can alter
protein expression of the targeted mRNA by different
mechanisms, such as translational repression and mRNA
degradation (21–24).
A number of non-canonical pathways for miRNA bio-
genesis have also been described (25–33). However, a
common feature of all other pathways is the cleavage of
the intermediate precursor by Dicer. One exception is the
processing of miR-451, which has been shown to bypass
Dicer cleavage and instead is cleaved by Argonaute-2
(Ago2) (34–37).
Mirtrons are a type of miRNA that are processed by a
non-canonical miRNA pathway. Mirtrons have a
pre-miRNA that is deﬁned by the entire length of the
intron in which it is located, and require pre-mRNA
splicing rather than the Microprocessor for the ﬁrst
step in their biogenesis. The biogenesis pathway for a
number of mirtrons has been characterized in Drosophila
melanogaster and Caenorhabditis elegans (38,39). The
pre-miRNA excised by splicing is initially in the form of
an intron lariat which is subsequently linearized by the
debranching enzyme, Ldbr (DBR1 in humans), allowing
the intron to form a structure that is exported to the
cytoplasm by XPO5 and recognized and cleaved by
the Dicer complex to form a mature miRNA (38,39).
In all cases, mirtronic miRNAs contain all or a portion
of either the 50 splice site, in the case of 50 miRNAs, or the
30splice site, if a 30 miRNA is formed. Thus, the only
known way that both the mRNA and miRNA can be
generated from the same primary transcript would be
for splicing to occur ﬁrst and the miRNA to be generated
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mirtrons (38,39).
Mirtrons have been documented in mammals, avians
and plants by deep-sequencing approaches (40–42). For
humans, 13 mirtrons were predicted based on their struc-
ture, conservation, location within small introns and
cloning evidence (40). Two mirtrons, miR-877 and miR-
1224, were shown to be insensitive to changes in cellular
DGCR8 or Drosha levels, as expected for a mirtron
(25,40,43). Mammalian mirtrons, miR-877, 1226 and
1224, have been shown to be splicing-dependent, based
on a GFP splicing reporter (44).
In this study, we investigated the biogenesis of predicted
human mirtrons in the context of their natural ﬂanking
exons and made the unexpected discovery that, while some
of the predicted mirtrons are splicing-dependent, a subset
we term ‘simtrons’ are not processed by the canonical
miRNA pathway or by the mirtron-processing pathway.
Rather, simtron biogenesis occurs by a novel pathway that
involves Drosha but does not require Drosha’s binding
partner DGCR8 or the endonuclease, Dicer. We further
demonstrate that this novel class of non-canonical
miRNAs is capable of gene silencing and associates with
all four of the human Argonaute proteins. The identiﬁca-
tion of simtrons expands the mechanisms by which small
RNAs can be generated to produce regulatory molecules.
MATERIALS AND METHODS
Primers
Primer and siRNA sequences are provided in
Supplementary Table S1.
Construction of plasmids
PKD1 exons 43–46, LRP1 exons 48–50 and DHX30 exons
20–22 were ampliﬁed from human genomic DNA by RT–
PCR using the Phire PCR kit (NEB). Primers for ampli-
ﬁcation had restriction sites incorporated on the termini.
PCR products were digested with BamHI and HindIII and
inserted into the similarly digested pTT3 plasmid (45)
using T4 DNA ligase. ABCF1 exons 12–15 were cloned
into the pCI vector (Promega) using the restriction sites
for Xho and NotI. Splicing mutations were made using the
Quik Change Lightening kit (Agilent) per manufacturer’s
instructions.
For construction of the miRNAs expressed in an
intergenic context, pcDNA-1225 and -877, the mirtonic
introns were PCR ampliﬁed with Phire polymerase
(NEB) using the previously constructed minigenes as tem-
plates and primers with restriction sites incorporated on
the termini. PCR products were digested with BamHI
and EcoR1 and inserted into the similarly digested
pcDNA3.1+plasmid (Invitrogen) using T4 DNA ligase.
For pmiRGLO-luciferase reporter plasmid construc-
tion, oligonucleotides miR-1225-5p Target 30-UTR and
miR-1225-5p Target 30-UTR R were annealed and
inserted into an XbaI- and XhoI-digested pmiRGLO
plasmid (Promega) as per manufacturer’s instructions.
Oligonucleotides miR-877 Target 30-UTR and miR-877
Target 30-UTR R were annealed and inserted into a
XbaI and XhoI digested pmiRGLO plasmid (Promega)
as per manufacturer’s instructions.
FLAG-pcK-Drosha (pFLAG-Drosha) and FLAG-
pcK-Dicer (pFLAG-Dicer) were generated by quick-
change mutagenesis of the pFLAG-TN-Drosha and
pFLAG-TN-Dicer (a generous gift of V.N. Kim)
plasmids, respectively, using the Quik Change
Lightening kit (Agilent) per manufacturer’s instructions.
All plasmid constructions were conﬁrmed by sequence
analysis.
Cell culture and transfection
HEK-293T, HeLa, NIH/3T3 and mouse embryonic ﬁbro-
blast Ago2 knockout cells (Ago2
 / ) (46) (a generous gift
from G.J. Hannon) were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine
serum. Optifect (Invitrogen) or Lipofectamine 2000
(Invitrogen) was used for transfection of HEK-293T
with plasmids as per manufacturer’s instructions.
Lipofectamine 2000 (Invitrogen) was used for transfection
of HeLa, NIH/3T3 and Ago2
 /  cells. RNA was isolated
after 48h.
For DGCR8 RNAi experiments, HeLa cells were trans-
fected with siRNA using Lipofectamine 2000 (Invitrogen)
as per the manufacturer’s instructions. Cells were trans-
fected with 32nM siRNA on the ﬁrst day and again after
48 and 96h. RNA was collected 72h after the ﬁnal siRNA
treatment.
For TN-Drosha experiments HEK-293T cells were
transfected with 3mg of pFLAG-TN-Drosha (a generous
gift from V.N. Kim) (47) with or without 3mg of minigene
plasmid or mock transfection control using Lipofectamine
2000 (Invitrogen). Cells were split 1:2, 24-h post-
transfection and RNA was collected 24h later.
For XPO5 RNAi experiments, HeLa cells were trans-
fected with 40nM siRNA using Lipofectamine 2000
(Invitrogen). After 24h, cells were transfected again with
40nM siRNA and 3mg of minigene plasmid. After 48h,
RNA was collected.
Mouse embryonic stem cell lines, Control (Dicer condi-
tional knockout) and Dicer knockout (Dicer
 / ) cells
(from G.J. Hannon) (48) and DGCR8 knockout
(DGCR8
 / ) cells (Novus Biologicals) were grown on a
gelatin layer in Knockout Dulbecco’s modiﬁed Eagle’s
medium (Gibco) supplemented with 15% ES cell FBS
(Gibco), 1% non-essential amino acids, 1% L-glutamine,
1% penicillin/streptomycin/Amphotericin B, 0.1%
ESGRO-LIF and 0.008% beta-mercaptoethanol. Cells
were transfected with 3mg of minigene plasmid using
Lipofectamine 2000 (Invitrogen) as per the manufacturer’s
instructions and RNA was collected after 48h.
RNA was collected for all experiments using Trizol
reagent (Invitrogen).
RT–PCR
Reverse transcription was performed using a High
Capacity Reverse Transcription kit (Applied Biosystems),
Superscript III (Invitogen) or GoScript (Promega) as per
manufacturer’s instructions. The same kits were used to
reverse transcribe miRNAs with gene-speciﬁc stemloop
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primers. PCR was performed with GoTaq (Promega)
and
32P-dCTP. Various PCR cycle numbers were tested
to insure ampliﬁcation in the linear range. Endogenous
simtrons and mirtrons were analysed following 35 PCR
cycles and minigene-derived miRNAs and snoRNA65
were analysed following 25 PCR cycles. miR-16 was
analysed after 20 cycles. All RNAs from immunopre-
cipitation experiments were subjected to 35 PCR cycles.
Ampliﬁcation products from stemloop PCR of
miRNAs were separated on 12% native or 15%
denaturing PAGE gels and mRNA products on 5%
native PAGE gels. Products were quantitated using a
Typhoon Phosphorimager (GE Healthcare).
Western blotting
Proteins were separated by sodium dodecyl sulphate
(SDS)–PAGE and transferred to Immobilon-FL
membrane (Millipore). Blots were probed with rabbit
polyclonal antibodies speciﬁc to DGCR8 (Novus
Biologicals) and mouse monoclonal antibodies speciﬁc to
b-actin (Sigma) followed by horseradish peroxidase
(HRP)-conjugated goat anti-mouse or anti-rabbit second-
ary antibody. Detection was preformed with Luminata
Forte Western HRP Substrate (Millipore). Quantitation
was preformed with NIH-ImageJ software.
Immunoprecipitation
HEK-293T cells were transfected with 3mg of minigene
plasmid and 18mg of pFLAG-GFP, Argonaute-1, (50) 2,
3, 4 (51) (Addgene), -Dicer or -Drosha. Cells were har-
vested after 48h and immunoprecipitation was preformed
using 20ml M2-FLAG beads (Sigma) in RSB-250.
Portions of the input (In), unbound (Un) and immunopre-
cipitated (IP) fractions were proteinase K (Promega)
treated and RNA was isolated by phenol/chloroform
extraction followed by ethanol precipitation. Isolated,
immunoprecipitated RNA was analysed using
radiolabelled stemloop RT–PCR as described earlier.
In vitro transcription of RNAs
T7-DNA templates were generated via RT–PCR. RNA
substrates were transcribed in vitro by T7 RNA polymer-
ase (Promega) in the presence of a-
32P UTP with 5  tran-
scription buffer (Promega), 100mM DTT, 2.5mM A, C
and G and 0.1mM U, RNase inhibitor (Promega) and T7
RNA polymerase (Promega). The reaction was incubated
for 1h at 37 C then treated with RQ1 DNase (Promega)
for 30min at 37 C. Reaction products were separated on a
5% denaturing PAGE gel, excised, eluted, ethanol
precipitated and resuspended in water prior to use.
In vitro processing of RNA
FLAG-Drosha and FLAG-DGCR8 (AddGene), FLAG-
Drosha alone, FLAG-TN-Drosha or FLAG-GFP were
overexpressed in HEK-293T cells and FLAG-tagged
proteins were isolated on M2-FLAG beads (Sigma).
Brieﬂy, 6mg of plasmid was transfected into cells using
Lipofectamine 2000 (Invitrogen) as per manufacturer’s
instructions. Approximately 48h after transfection, cells
were washed with phosphate buffered saline, harvested
and lysed via sonication in lysis buffer (20mM Tris–HCl
pH 8.0, 100mM KCl and 0.2mM EDTA). Lysate was
incubated with M2-FLAG beads (Sigma) for 1h at 4 C.
Beads were washed ﬁve times with lysis buffer and 15mlo f
beads/buffer were combined with 100000cpm RNA, 10 
reaction buffer (64mM MgCl2) and RNase inhibitor
(Promega) for 90min at 37 C. Alternatively, cell lysates
were directly incubated (referred to as whole-cell extracts,
WCE) with in vitro transcribed RNA. Products were
phenol/chloroform extracted and ethanol precipitated
and analysed on 8% denaturing PAGE gels.
Luciferase assay
HEK-293T cells were transfected with 0.4 or 1mgo f
minigene plasmid and 10ng of pmiRGLO (Promega)
using Optifect (Invitrogen). After 24h, cells were split in
triplicate into 96-well black bottom plates. After 24h, the
media was changed to Dulbecco’s modiﬁed Eagle’s
medium High Glucose without phenol red and luciferase
and renilla expression from the pmiRGLO plasmid was
quantitated using the Dual-Glo Luciferase assay system
(Promega) and a Synergy HT luminometer (BioTek) as
per the manufacturer’s instructions. For each experiment,
all wells were analysed in triplicate. Values greater than
±1 SD within the triplicate measurements were not con-
sidered. For the mismatch controls, miR-877 was trans-
fected with the luciferase reporter plasmid for miR-1225
and miR-1225 was transfected with the luciferase reporter
plasmid for miR-877. The seed sequence for miR-877 and
miR-1225 are not matched and thus serve effectively as
mismatch controls.
Statistics
The Student’s t-test was used to analyse all experimental
results with the exception that the Wilcoxon matched pairs
signed-rank tests was used for sample sets that did not
have Gaussian distributions. Data were considered signiﬁ-
cant when P 0.05.
RESULTS
Identiﬁcation of simtrons, splicing-independent mirtron-
like miRNAs
Mammalian mirtrons have been previously predicted by
computational and sequencing approaches (40). In order
to be deﬁnitively classiﬁed as a mirtron, miRNA produc-
tion must require splicing. To determine whether predicted
mammalian mirtrons are splicing-dependent in the context
of their natural host gene exons, we constructed minigene
expression plasmids comprised of the mirtron and
ﬂanking exons from ABCF1 (miR-877), DHX30
(miR-1226), PKD1 (miR-1225) and LRP1 (miR-1228)
(Figure 1A). In addition, a version of each minigene was
made in which single nucleotide changes were introduced
into the 50 splice site and the 30 splice site to inactivate
splicing of the mirtronic intron (ss, Figure 1A).
Compensatory mutations at the 50 and 30 splice sites
4628 Nucleic Acids Research, 2012,Vol.40, No. 10Figure 1. Identiﬁcation of splicing-independent mirtron-like miRNAs (simtrons). (A) Minigene structures. Boxes and lines indicate exons and
introns, respectively. Splice site mutations are in bold and underlined. Arrows refer to the 50 and 30 splice sites (ss). (B) Splicing-dependent
mirtrons. Left panels: splicing analysis of host gene transcripts. wt, splicing-deﬁcient (ss) minigene transcripts or empty vector control ( ) were
transfected into HEK-293T cells and mRNA splicing was analysed by radiolabelled RT–PCR. GAPDH was used as a loading control. Unspliced
indicates the mRNA product retaining only the mirtronic intron, all other introns were excised. Middle panels: miRNA expression in
minigene-transfected HEK-293T cells was analysed by radiolabelled, stemloop RT–PCR with snoRNA65 (sno65) used as a loading control. +RT
indicates RNA that was reverse transcribed with stemloop primers and  RT indicates RNA that was not reverse transcribed but had stemloop
primers added as a control. M indicates a synthetic size marker. Filled circle indicates a non-speciﬁc primer dimer. Right panels: Quantitation of
miRNA expression normalized to sno65. nd indicates that the miRNA was not detected. Bars represent the average values±SEM; ABCF1/
miR-877n=12, DHX30/miR-1226n=11. (C) Splicing-independent mirtron-like miRNAs analysed as in B. PKD1/miR-1225, n=8; LRP1/
miR-1228, n=9.
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ture of the stem of each mirtron.
These minigene reporters were transiently transfected
into HEK-293T cells, RNA was isolated and mRNA
splicing of minigene transcripts and miRNA production
from the minigene-derived RNA was analysed. Given that
stemloop RT–PCR (49) is the basis for detection in pre-
designed Taqman miRNA assays (Applied Biosystems),
we used a modiﬁed version of this method, radiolabelled
stemloop RT–PCR, for analysis of miRNAs generated
from the minigene transcripts. This method was also
chosen because of its detection sensitivity and track-record
of speciﬁcity (52,53). The speciﬁcity of the stemloop
primers for our substrates was conﬁrmed through a
number of control experiments. First, we demonstrate
that DNA is not being ampliﬁed, as reverse transcription
is required for product detection (Figure 1B and C).
Second, the stemloops are speciﬁc for amplifying the
targeted terminal RNA sequence, as a synthetic
pre-mRNA comprised of the intron and ﬂanking exons
is not detected in the stemloop RT–PCR reaction
(Supplementary Figure S1A and B), whereas a synthetic
RNA substrate with the 30 termini corresponding to the
stemloop is ampliﬁed (Supplementary Figure S1A and C).
These controls conﬁrm the effectiveness and speciﬁcity of
the radiolabelled stemloop RT–PCR methodology.
Each of the wild-type (wt) minigene-derived RNA tran-
scripts gave rise to mature miRNA, as well as spliced
mRNA (Figure 1B and C). miRNA species from both
the 50 and 30 arm of these miRNAs have been identiﬁed
in small RNA libraries from deep sequencing (54,55).
Sequencing of the products conﬁrmed that the miRNAs
correspond to those previously sequenced from mammals
and predicted to be mirtrons (40,54,55) (Supplementary
Figure S2). The minigene transcripts with splice site mu-
tations (ss) were not spliced and yielded RNA tran-
scripts that retained the mirtronic intron (Figure 1B and
C). As expected for mirtrons, the ABCF1ss and
DHX30ss minigene transcripts did not produce
miR-877 or miR-1226, respectively (Figure 1B). This
result demonstrates the existence of splicing-dependent
mirtrons in mammalian cells in the context of their host
gene.
Unexpectedly, PKD1ss and LRP1ss minigene tran-
scripts, though not spliced, produced miR-1225-5p
(referred to as miR-1225) and miR-1228, respectively, at
similar amounts as their wt counterparts (Figure 1C).
These results were conﬁrmed using Taqman qPCR
(Supplementary Figure S3), demonstrating that miR-
1225 and miR-1228 are produced in the absence of
splicing. Two species of mature miR-1228 were
produced from both the wt and ss minigenes one of
which had two additional 30 nt as conﬁrmed by sequencing
(Supplementary Figure S2), indicating 30 heterogeneity.
Stemloops speciﬁc for all previously reported 30-ends
were included in the reaction in order to detect the differ-
ent 30-ends of the miRNA. This extended 30-end has been
reported previously for miR-1228 (54,55). These results
demonstrate that miR-1225 and miR-1228 are not
strictly splicing-dependent mirtrons, as they can be
generated in the absence of splicing. We propose to call
this new type of miRNAs splicing independent
mirtron-like miRNAs or ‘simtrons’.
Simtron biogenesis involves Drosha but
does not require DGCR8
The Microprocessor, composed of Drosha and DGCR8 is
required for the ﬁrst cleavage step to generate canonical
pre-miRNAs, but is not required to generate mirtrons,
which are excised from the primary RNA transcript
during pre-mRNA splicing. To test whether biogenesis
of endogenous miR-1225 and miR-1228, requires the
Microprocessor, we reduced DGCR8 expression in HeLa
cells using DGCR8-speciﬁc siRNAs, and examined en-
dogenous miRNA levels. DGCR8 mRNA was reduced
by 63% (Figure 2A) and protein by 46% (Figure 2B),
and resulted in a 40% reduction in miR-16 (P=0.0313)
(Figure 2C), a canonical, DGCR8-dependent miRNA
(8,56,57). This result conﬁrms that DGCR8 was effectively
reduced in the cells.
The abundance of the splicing-dependent mirtrons,
miR-1226 and miR-877, did not change signiﬁcantly fol-
lowing DGCR8-knockdown (Figure 2C), conﬁrming that
miR-1226 and miR-877 are bona ﬁde mirtrons. The
splicing-independent simtrons, miR-1225 and miR-1228,
were also not signiﬁcantly affected by DGCR8-
knockdown (Figure 2C), suggesting that endogenous
miR-1225 and miR-1228 are not dependent on the canon-
ical miRNA biogenesis pathway.
We next tested whether simtron processing requires
Drosha, the endonuclease component of the
Microprocessor. Knockdown of Drosha using siRNAs
reduced Drosha by >50% but did not signiﬁcantly
reduce miR-16 production, suggesting that the enzyme
was not sufﬁciently reduced to affect overall miRNA pro-
duction. Efforts to further reduce Drosha have been un-
successful largely due to cellular toxicity. As an alternative
approach to test the requirement of Drosha in simtron
processing, we expressed a transdominant negative
Drosha (TN-Drosha) (47) in HEK-293T cells (Figure
2D–G). The endonuclease domains in TN-Drosha
contain the mutations E1045Q and E1222Q, which
prevent nuclease activity at the 30-end and 50-end of the
pre-miRNA hairpin, respectively, while Drosha binding to
the pre-miRNA is not affected (4). Endogenous miR-16
was reduced by 38% (P=0.0213) whereas endogenous
miR-877, miR-1226, miR-1225 and miR-1228 were not
affected (Figure 2E). These results suggest that endogen-
ous miR-1225 and miR-1228 are not dependent on
Drosha for processing.
It is possible that miR-1225 and miR-1228 production
is only dependent on Drosha and DGCR8 when
pre-miR processing cannot occur via splicing. To test
this idea, we expressed TN-Drosha in HEK-293T cells
co-transfected with wt and ss minigenes. miR-1225 and
miR-1228 derived from the wt minigenes were not affected
(miR-1225) or increased (miR-1228) by 27% (P=0.0239)
when expressed with the dominant negative form of
Drosha (Figure 2F and G). In contrast miR-1225 and
miR-1228 derived from the ss minigenes decreased by
40% (P=0.0456) and 24% (P=0.0499), respectively,
4630 Nucleic Acids Research, 2012,Vol.40, No. 10Figure 2. Simtron biogenesis involves Drosha but not DGCR8. Knockdown of DGCR8 in HeLa cells using siRNA was quantitated by (A) RT–
PCR analysis of DGCR8 mRNA and (B) western blot analysis of DGCR8 protein expression. The percentage of knockdown of DGCR8 was
quantitated for DGCR8 mRNA using the equation 100 [((DGCR8knockdown/GAPDH)/(DGCR8control/GAPDH)) 100], n=5 and for DGCR8
protein using the equation 100 [((DGCR8knockdown/ -actin)/(DGCR8control/ -actin)) 100]. (C) Changes in endogenous miRNA levels following
DGCR8 knockdown were analysed by stemloop RT–PCR analysis. miR-16 is a canonical miRNA control and sno65 is a loading control.
Graph shows quantitation of miRNA abundance using the equation: (miRNAexperimental condition/sno65)/(miRNAcontrol/sno65). n=4 for all
miRNAs except for miR-16, n=5; asterisk indicates P 0.05 (Wilcoxon matched pairs signed-rank test). M indicates a synthetic size marker
and ﬁlled circle indicates a non-speciﬁc primer dimer. (D) RT–PCR analysis of Drosha mRNA following expression of TN-Drosha in HEK-293T
cells. (E) The effect of TN-Drosha expression on endogenous miRNA abundance was analysed by stemloop RT–PCR. Graph shows quantitation of
miRNA abundance using the same equation as in C, n=6; asterick indicates P 0.05 (Student’s t-test). (F) Stemloop RT–PCR analysis of
minigene-derived miR-877, 1226, 1225, 1228 and endogenous miR-16 isolated from HEK-293T cells transiently transfected with TN-Drosha.
sno65 was used as a control. TN-Drosha mRNA expression in HEK-293T cells was analysed by radiolabelled RT–PCR. GAPDH was used as a
control. (G) Quantitation of miRNA abundance relative to sno65 using the equation: miRNA/sno65. n=3 for miR-877, 1226 and 1225, n=5 for
miR-1228 and n=14 for miR-16; *P 0.05, ***P 0.0001 (). Data sets were analysed using the Student’s t-test with the exception of miR-16, which
was analysed using the Wilcoxon matched pairs signed-rank test. In all panels, bars represent the average±SEM. The horizontal dotted line
indicates normalized control levels.
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decrease is comparable to the 40% decrease (P=0.0001)
of the canonical miRNA miR-16. These results suggest
that simtrons are sensitive to Drosha activity only when
splicing is inactive, perhaps indicating that simtrons can
be excised by either the mirtron processing pathway or by
a pathway involving Drosha.
To further test whether the canonical miRNA pathway
is required for miR-1225 and miR-1228 processing when
splicing is inactive, we analysed miR-1225 and miR-1228
processing in a DGCR8 knockout mouse embryonic stem
cell line (DGCR8
 / ) (58). wt and ss minigenes for
PKD1 (miR-1225) and LRP1 (miR-1228) were transfected
into the DGCR8
 /  cells and RNA was subsequently col-
lected and analysed for miRNA production. Endogenous,
mature miR-16 was not detected in these cells, as expected
for a canonical miRNA (Figure 3A). In contrast, mature
miR-1225 and miR-1228 abundance did not change sig-
niﬁcantly in DGCR8
 /  cells compared to control cells
(Figure 3A). These results indicate that DGCR8 is not
required for miR-1225 or miR-1228 processing. Taken
together, our results demonstrate that miR-1225 and
miR-1228 are neither mirtrons (dependent on splicing
for biogenesis) nor canonical miRNAs (dependent on
Drosha and DGCR8). Rather, it appears that splicing
may be one, but not the only mechanism for production
of these miRNAs and that simtronic miRNAs can be
generated by an alternative processing pathway that
does not require splicing or DGCR8.
Simtron biogenesis does not require Dicer, Ago2 or XPO5
To further elucidate the requirements for simtron biogen-
esis, we tested the requirement of other factors involved in
the maturation process of miRNAs. In the canonical
miRNA biogenesis pathway Dicer, or in one case, Ago2,
processes pre-miRNA into mature miRNA. Biogenesis of
mirtrons in D. melanogaster and C. elegans has also been
shown to require Dicer and XPO5 (12,38,39). To deter-
mine whether the simtrons, miR-1225 and miR-1228,
require XPO5, Dicer or Ago2, we transiently transfected
wt and ss minigenes into Dicer knockout mouse embry-
onic stem cells (Dicer
 / ), Ago2 knockout mouse embry-
onic ﬁbroblasts (Ago2
 / ) or control cells (NIH-3T3 or
Dicer conditional mouse embryonic stem cells). miR-16
was not detected in the Dicer
 /  cells and was reduced
dramatically in Ago2
 /  cell (Figure 3A and C) as
expected for a canonical miRNA. In contrast, there was
no signiﬁcant change in miR-1225 or miR-1228 produc-
tion from either the wt or ss minigenes in either
knockout cell line relative to control cells, though
miR-1225 increased slightly from both wt and ss
minigenes in the Ago2
 /  cells and the Dicer
 /  cells
(Figure 3A and C). The production of both miR-1225
and miR-1228 in the absence of Dicer and Ago2 indicates
that maturation of these simtrons does not require these
enzymes for processing.
The processing of miR-1225 in the absence of Dicer was
unexpected, as most miRNAs require Dicer cleavage to
produce a mature miRNA. To further test the Dicer re-
quirement, pFLAG-Dicer constructs were expressed in
HEK-293T cells. FLAG-Dicer was immunoprecipitated
from the cell lysates and co-immunoprecipitated
miRNAs were analysed. Consistent with our results in
the Dicer
 /  cells, miR-1225 and miR-1228 were not
detected above background levels in immunoprecipitates
from cells co-transfected with the miR-1225 or miR-1228
ss minigenes (Figure 3B). In contrast, miR-1225,
miR-1228 and miR-877 from the wt minigenes were
efﬁciently co-immunoprecipitated with FLAG-Dicer
(Figure 3B). These results suggest that miR-1225,
miR-1228 and miR-877 generated from the mirtronic pro-
cessing pathway interact with Dicer, and the simtrons
generated by a splicing-independent pathway, do not
interact with Dicer.
In the canonical miRNA biogenesis pathway XPO5
exports pre-miRNA to the cytoplasm. To test the require-
ment for XPO5 in the simtron biogenesis pathway, HeLa
cells were transiently transfected with wt or ss minigenes
and XPO5 siRNA. XPO5 expression was reduced by 87%
relative to cells treated with a control siRNA and resulted
in a 73% reduction in the mirtron miR-877 and a 415%
increase in pre-miR-877 (Figure 3D), suggesting that in
the absence of XPO5, pre-miRNA is trapped in the
nucleus, unable to enter the cytoplasm for processing to
a mature miRNA. In contrast, the simtrons, miR-1225
and miR-1228, were not affected by XPO5 knockdown
(Figure 3D), suggesting that simtrons do not require
XPO5 for production of a mature miRNA.
Processing of simtrons by Drosha
Experiments with a dominant negative form of Drosha
(Figure 2F and G), suggest that Drosha is involved in
simtron biogenesis. Because Drosha was the only canon-
ical miRNA processing factor analysed that had any in-
ﬂuence on simtron biogenesis, we further tested the role of
Drosha in the cleavage of the simtron pre-miRNA from
the primary transcript. First, interactions between
simtrons and Drosha were examined. For this,
FLAG-Drosha was co-expressed with 1225wt or ss
minigenes or 877wt in HEK-293T cells. FLAG-Drosha
was immunoprecipitated and the co-immunoprecipitated
pre-miRNAs were analysed. Pre-miR-1225 derived from
both wt and ss transcripts immunoprecipitated with
FLAG-Drosha, whereas pre-miR-1225 was not
immunoprecipitated from lysates of mock transfected
cells (Figure 4A). miR-877 did not immunoprecipitate
with FLAG-Drosha (Figure 4A) further verifying it as a
mirtron. These results demonstrate that Drosha interacts
with the simtron miR-1225.
Next, an in vitro Drosha processing assay was used to
test more directly whether Drosha promotes pre-miRNA
processing from a primary RNA transcript. Plasmids
expressing FLAG-Drosha, FLAG-DGCR8 or FLAG-
TN-Drosha were expressed in HEK-293T cells and
immunoprecipitated with anti-FLAG M2 beads.
Immunoprecipitated FLAG-tagged proteins were incu-
bated with a radiolabelled, in vitro transcribed and
puriﬁed pri-miRNA consisting of the miRNA containing
intron and ﬂanking exons, or the ﬂanking  120nt in the
case of miR-16. The puriﬁed Drosha/DGCR8 complex
4632 Nucleic Acids Research, 2012,Vol.40, No. 10Figure 3. Simtron biogenesis does not require DGCR8, Dicer, Ago2 or XPO5. (A) RT–PCR analysis of minigene-derived host gene mRNA
and stemloop RT–PCR analysis of minigene-derived miRNA and endogenous miR-16 in Dicer and DGCR8 knockout mouse embryonic stem
cells transfected with the wt or splicing-deﬁcient minigene (ss) or empty vector control ( ). sno65 was used as a loading control. Graphs show
quantitation of miRNA using the equation: (miRNAexperimental condition/sno65)/(miRNAcontrol/sno65). Bars represent the average±SEM, n=3.
The horizontal dotted lines indicate normalized control levels. (B) Stemloop RT–PCR analysis of miR-1225 and miR-1228 immunoprecipitated
from HEK-293T cell lysates that were transiently transfected with wt or ss minigenes, or miR-877 from wt minigene along with pFLAG-Dicer
(Dicer) or without ( ) and immunoprecipitated with an antibody against the FLAG epitope. Input refers to cell lysates before FLAG immunopre-
cipitation; Un is the unbound fraction and IP is the immunoprecipitated fraction. Un is 1/20 IP and Input is 1/5 IP. The graph represents the percent
of the mature miRNA found in the IP fraction versus the amount that remained in the Un fraction using the equation: (IP/(IP+(Un 20)) 100).
(C) Stemloop RT–PCR analysis of minigene-derived miR-1225, miR-1228 and endogenous miR-16 from Ago2 knockout mouse embryonic ﬁbro-
blasts. sno65 was used as a loading control. Cells were transiently transfected with wt or ss minigenes or empty vector control ( ). Graph shows
quantitation of miRNA abundance using the same equation as in A. Bars represent the average±SEM, n=3 and *P 0.05 or **P 0.01, Student’s
t-test. The horizontal dotted lines indicate normalized control levels. (D) Stemloop RT–PCR and RT–PCR analysis of miR-877 (left panel),
miR-1225 (middle panel) and miR-1228 (right panel) minigene-expression in HeLa cells following siRNA-directed knockdown of XPO5. sno65 is
a loading control for miRNA using stemloop RT–PCR and GAPDH is a loading control for RT–PCR of XPO5 mRNA.
Nucleic Acids Research, 2012,Vol.40, No. 10 4633efﬁciently processed the canonical pri-miR-16 ( 60nt
pre-miRNA) substrate as well as the wt and ss
versions of the simtron, miR-1225 ( 90nt pre-miRNA),
but not the mirtron, miR-877 as expected ( 86nt
pre-miRNA) (Figure 4B). wt Pre-miR-1225 (90nt) was
produced when Drosha was overexpressed with its
binding partner DGCR8, whereas ss pre-miRNA-1225
was generated from incubation with Drosha immunopre-
cipitates alone or in combination with DGCR8. Simtron
miR-1225, miR-16 and miR-877 were not processed by
immunoprecipitates from mock transfected cell lysates
( ), FLAG-GFP or FLAG-TN-Drosha lysates. These
in vitro data support our in vivo data that simtrons, but
not mirtrons, can be processed by Drosha.
Figure 4. Immunoprecipitation and in vitro processing of simtrons with Drosha. (A) Pre-miR-1225 co-immunoprecipitates with Drosha. Pre-miR-
1225 derived from wt and ss minigenes and pre-miR-877 from wt minigene were transiently transfected into HEK-293T cells with
pFLAG-Drosha (Drosha) or without ( ), and immunoprecipitated with an antibody against the FLAG epitope. Isolated pre-miRNAs were
analysed by radiolabelled stemloop RT–PCR and products were separated by 12% native PAGE. Input (In) refers to cell lysates before FLAG
immunoprecipitation; Un is the unbound fraction and IP is the immunoprecipitated fraction. Un is 1/20 IP and Input is 1/5 IP. The graph
represents the percent of the pre-miRNA found in the IP fraction versus the amount that remained in the Un fraction using the equation: (IP/
(IP+(Un 20)) 100). (B) Drosha-dependent in vitro simtron processing. Radiolabelled RNA transcribed from a PKD1 wt or ss, ABCF1 wt
or pri-miR-16-1 DNA template was incubated with the FLAG-immunoprecipitates from HEK-293T cells, or with HEK-293T WCEs from cells
that were not transfected. FLAG-immunoprecipitates were derived from cells transfected with mock transfection ( ), pFLAG-GFP (GFP),
pFLAG-Drosha (Drosha), pFLAG-Drosha and pFLAG-DGCR8 (Drosha+DGCR8), pFLAG-TN-Drosha (TN Drosha), or FLAG-M2-
beads that were incubated with lysis buffer but no cell lysate ( lysate). Template RNA was included as a control (RNA). Reaction
products were separated by 8% denaturing PAGE. The sizes of pre-miRNAs are indicated. Asterisk indicates uncharacterized miR-16
cleavage fragments (59).
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Although processing of simtrons does not require splicing,
simtron processing may depend on its location within the
intron, perhaps involving the recruitment of splicing
factors via cis-acting sequences within the ﬂanking
exons. To test this idea, we removed the intron from the
host gene and inserted it into the pcDNA3.1+ plasmid
under the control of a CMV promoter, effectively
changing the intronic location to an intergenic one
(Figure 5A). We transiently transfected the plasmids into
control, DGCR8
 /  or Dicer
 /  cells and analysed RNA
abundance. As expected, miR-877, which is splicing-
dependent, was not produced in the absence of the
ﬂanking exons in either control, DGCR8
 /  or Dicer
 / 
cells (Figure 5B). However, intergenic miR-1225 derived
from wt and ss minigenes were produced in the absence
of their ﬂanking exons and in the absence of Dicer and
DGCR8 (Figure 5B and C), indicating that simtron bio-
genesis is not context-dependent and that all the sequence
requirements necessary for processing of the miRNAs are
contained within the intronic sequence. Similar results
were obtained for miR-1228 (Supplementary Figure S4A
and B).
Simtrons function in gene silencing and bind Argonaute
proteins
To test whether small RNAs generated from mammalian
simtrons and mirtrons are functional miRNAs, we
assessed the gene-silencing capabilities of miR-1225,
miR-1228 and miR-877 in HEK-293T cells using a
luciferase reporter assay. Two exact complement target
sequences for miR-1225, miR-1228 or miR-877 were
cloned into the 30-UTR of the luciferase gene of the
pmiRGLO plasmid, which also has a renilla reporter for
signal normalization. The wt or ss minigenes were tran-
siently transfected with a match or mismatched luciferase
reporter plasmid. The wt miR-877 minigene reduced
luciferase activity of its pmiRGlo-derived target by up to
30%±6 as compared to mismatch control (Figure 6).
The ABCF1ss minigene does not produce miRNA,
and, as expected, did not reduce luciferase activity
(Figure 6). These results demonstrate that human
mirtrons are functional in targeted gene silencing.
The simtron, miR-1225, produced from either the wt or
ss plasmid, induced a dose-responsive reduction in
luciferase activity by up to 52%±11 and 73%±5, re-
spectively, compared to the mismatch control (Figure 6).
Similar to miR-1225, miR-1228 also induced a
dose-responsive reduction in luciferase activity by
23%±8 and 29%±11, respectively, compared to a
mismatch control (Supplementary Figure S4C). These
results demonstrate that miR-1225 and miR-1228 are
capable of silencing a target transcript in a dose-dependent
manner and thus indicate that miRNAs derived from the
simtron processing pathway can function as miRNAs.
Canonical miRNAs are loaded into the RISC complex
with Ago proteins to produce a functional complex for
silencing. To test whether simtrons associate with the
RISC complex, we performed immunoprecipitation
assays on all four human Ago proteins. We found that
all four Ago proteins pulled down wt and ss versions
of miR-1225 (Figure 7). All four Ago proteins also
pulled down wt and ss-derived miR-1228, with the ex-
ception of Ago4 which did not pull down ss-derived
miR-1228 (Supplementary Figure S4D and E).
Canonical miR-16 also interacted with all four Ago
proteins. Although a detectable amount of snoRNA65
immunoprecipitated with the Ago proteins, it was signiﬁ-
cantly less than the miRNAs and therefore substantiates
the speciﬁc interaction of the Ago proteins with the
Figure 5. Simtron processing is context independent. (A) Diagram
comparing intronic and intergenic pre-miRNA expression. (B) Control,
Dicer (Dicer
 / )o rDGCR8 (DGCR8
 / ) knockout mouse embryonic
stem cells were transiently transfected with the intergenic wt minigene,
or intergenic splicing-deﬁcient minigene (ss). Minigene-derived
miRNAs and endogenous miR-16 were analysed by stemloop RT–
PCR. Left panel: simtron miR-1225. Right panel: mirtron miR-877.
sno65 was analysed as a loading control. (C) Graph shows quantitation
of miR-1225 abundance using the equation: (miRNADicer /  or DGCR8 /
 /sno65)/(miRNAcontrol/sno65). Bars represent the average values
±SEM, n=4 for Dicer
 /  and n=3 for DGCR8
 / . The horizontal
dotted line indicates normalized control cell levels.
Nucleic Acids Research, 2012,Vol.40, No. 10 4635miRNAs. Taken together, these results demonstrate the
existence of a novel processing-pathway that generates
small RNAs that can function to silence gene expression.
DISCUSSION
In this study, we identify small regulatory RNAs that are
processed by a non-canonical biogenesis pathway that
involves Drosha, but does not require DGCR8 or the
other components of the canonical biogenesis pathway.
These miRNAs were originally predicted to be mirtrons,
due to their predicted hairpin structure, location within
short introns, and identiﬁcation from deep-sequencing
analysis (40). Although we conﬁrm that the predicted
mammalian mirtrons, miR-877 and miR-1226 are,
indeed, splicing-dependent in the context of their natural
host gene, two other predicted mirtrons, miR-1225 and
miR-1228 do not require splicing for their biogenesis.
We classify these miRNAs as ‘simtrons’ (splicing-
independent mirtron-like miRNAs), for their resemblance
to mirtrons in their structure and genomic context
spanning introns. To our knowledge, simtrons are the
only class of miRNAs characterized to date that are pro-
cessed in a manner that does not require splicing, the
Microprocessor, Dicer or Ago2.
A number of non-canonical miRNAs have been
described. However, they all require Dicer to produce
the mature miRNA. Flynt et al. (60) discovered a
miRNA in Drosophila, whose 50 pre-miRNA end is
generated as a result of splicing and whose 30
pre-miRNA end is generated by exosome-mediated
trimming. These 30 tailed mirtrons are distinct from
simtrons because they require splicing. Endogenous
shRNAs are non-canonical miRNAs that do not require
Drosha or splicing but are cleaved by Dicer to generate a
mature miRNA (25). Another class of non-canonical
miRNAs is encoded by a murine herpesvirus and pro-
cessed by tRNAseZ rather than by Drosha (26).
Likewise, endogenous siRNAs are generated from the se-
quential processing of long hairpins by Dicer but are not
considered miRNAs because they produce many different
small RNAs (1). Finally, miRNAs have been identiﬁed
that are derived from snoRNAs and tRNAs by
non-canonical pathways that do not require the
Microprocessor but require Dicer (25,27–31,33). These
examples highlight the diversity of small RNAs and
their processing pathways in the cells.
We demonstrated that simtrons are distinct from other
classes of small RNAs in that they are not processed by
Dicer or Ago2 (Figure 3), and yet are functional in gene
silencing (Figure 6 and Supplementary Figure S4C).
Figure 7. Simtrons associate with Argonaute proteins. (A) miR-1225
derived from wt and ss minigenes were co-transfected with
pFLAG-GFP, pFLAG-Ago1, pFLAG-Ago2, pFLAG-Ago3, pFLAG-
Ago4 or mock ( ) into HEK-293T cells. FLAG-tagged proteins were
immunoprecipitated from cell lysates and associated miRNAs
were analysed by radiolabelled stemloop RT–PCR. Un indicates the
unbound fraction, and IP is the immunoprecipitated miRNA. For
wt minigenes, unbound is 1/20 of IP. For ss minigenes, unbound is
1/5 of IP. Sno65 is a control non-coding RNA. miR-16 is a canonical
miRNA control. (B) The graphs represent the percent of miRNA in
the IP fraction as determined using the equation: (IP/(IP+(Un 20
or 5)) 100). Left panel: wt miR-1225, Right panel: ss miR-1225.
Figure 6. Mammalian mirtrons and simtrons function in silencing.
Luciferase expression in HEK-293T cells transiently co-transfected
with pmiRGLO with matching miRNA target sequences or
mis-match miRNA target sequences and two different concentrations
(0.4 or 1mg) of the wt or splicing-deﬁcient (ss) minigene. Horizontal
dotted line represents the normalized mismatch control value. The fol-
lowing equation was used to analyse the data: [(Luciferase Target/
Renilla)miR_match]avg/[(Luciferase Target/Renilla)miR_mismatch]avg. Each
sample was analysed in triplicate. Bars represent the average±SEM,
n=5 independent experiments.
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of mammalian mirtrons, it is possible, and perhaps likely,
that the processing pathway responsible for the biogenesis
of this non-canonical type of miRNA has a wider range
of substrates. Indeed, several studies have observed
miRNAs whose abundance, as determined by large-scale
sequencing analysis, is not altered in Dicer knockout,
Drosha knockout or DGCR8 knockout cells (25,61), sug-
gesting that additional processing pathways exist.
Our data indicate that Drosha is involved in the pro-
cessing of simtrons, though this may not be a strict re-
quirement. We also show that DGCR8 is not required
for simtron processing, though we cannot exclude the pos-
sibility that DGCR8 may be involved in simtron biogen-
esis at some level (Figures 2–4). These ﬁndings distinguish
simtrons from other miRNAs. A Drosha complex that
does not contain DGCR8 has been identiﬁed but was
reported to be less efﬁcient at miRNA processing than
the complex containing both DGCR8 and Drosha (8). It
is possible that this alternative Drosha complex, that lacks
DGCR8, processes simtrons. Although Drosha contains a
double-stranded RNA binding domain (DSB), it appears
to require an adaptor, such as DGCR8, for proper pos-
itioning and precise cleavage (62). DGCR8 functions as an
anchor that recognizes both dsRNA and ssRNA and
directs Drosha to cleave the stemloop  11bp from the
dsRNA/ssRNA junction (5). Drosha is capable of
cleaving hairpin-structured mRNA without producing
miRNAs (61), however, this is the ﬁrst evidence that
Drosha can process a subclass of miRNAs in the
absence of DGCR8. It is possible that another RNA
binding protein plays a role similar to DGCR8 in the pro-
cessing of some miRNAs such as simtrons. A number of
splicing factors, for example have been shown to promote
Drosha cleavage and silencing (63–66). Such a factor,
which binds in the intron, could potentially act as a
cofactor for Drosha cleavage of simtrons. Indeed,
though DGCR8 is not required for simtron processing
(Figure 3A), it appears to enhance processing in vitro
(Figure 4B) possibly by co-immunoprecipitating an im-
portant co-factor or by stabilizing Drosha in the in vitro
reaction.
Interestingly, simtrons generated from both the wt and
splicing-deﬁcient minigene transcripts immunopre-
cipitated with Drosha (Figure 4A), suggesting that
Drosha processing by the simtron pathway may occur
even when splicing is active. In this case, splicing and
Drosha processing may be in competition. Competition
between splicing and Drosha processing is further sup-
ported by results from experiments with the dominant
negative form of Drosha. Only miR-1225 derived from
the splicing deﬁcient transcripts (ss) was reduced as a
result of TN-Drosha expression. Reduction of Drosha
activity is not expected to affect miR-1225 levels from
the wt transcript because splicing can generate the
pre-miR-1225 via the mirtron pathway. Processing of the
miR-1225 by the mirtron pathway is also suggested by the
interaction of mature miR-1225 with Dicer. The simtron
pathway, on the other hand, does not require Dicer
(Figure 3A), and miR-1225 generated by this pathway
does not interact with Dicer (ss, Figure 3B). Taken
together, these results suggest that miR-1225 can be
excised from the host gene RNA transcript by either the
mirtron pathway (Drosha/DGCR8-independent, Dicer-
dependent) or the simtron pathway (involving Drosha
but DGCR8 and Dicer-independent) (Figure 8).
Our results indicate that Drosha is involved in the pro-
cessing of simtrons, however, it seems unlikely that
Drosha alone completes all steps of simtron processing.
Known canonical and non-canonical miRNA processing
pathways require two endonucleolytic cleavage events,
carried out by distinct enzymes, to generate a mature
miRNA. There are a number of human proteins that are
predicted to have RNase activity (67). For example,
human RNase P and tRNAse Z generate the 50 and
30-ends of tRNAs, respectively (68,69), and could
feasibly recognize the highly structured simtronic introns
and cleave the intron to generate the pre-miRNA.
Additionally, the human tRNA splicing endonuclease
complex cleaves both the 50 and 30 splice sites of a
Figure 8. Proposed model of simtron biogenesis compared to other
miRNA processing pathways. The pathways shown begin with the
primary transcript and end with the mature product. Left: simtron
pathway, Middle: mirtron pathway, Right: canonical miRNA
pathway. Exons are depicted as boxes and introns and miRNAs as
lines. Each protein or protein complex is labelled. Proteins labelled
with question marks are proposed but not known. Simtrons (such as
miR-1225 and miR-1228) processing from the intron involves Drosha
and possibly an unknown binding partner. Simtrons are further pro-
cessed by unknown factors and enter the RISC complex with any of the
four human Argonaute proteins. Mirtrons (such as miR-877 and
miR-1226) are excised from the host gene by the spliceosome, are
debranched, exported from the nucleus by exportin5 (XPO5), cleaved
by Dicer and enter the RISC complex. Canonical miRNAs (such as
miR-16) are processed by Drosha and DGCR8, exported from the
nucleus by XPO5, cleaved by Dicer and enter the RISC complex. All
three pathways result in functional miRNAs.
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(70,71). It is therefore possible, that one of these enzymes
also plays a role in simtron biogenesis.
The simtron biogenesis pathway appears to follow trad-
itional miRNA assembly into the RISC complex with Ago
proteins (Figure 7 and Supplementary Figure S4D and E)
and targeting (Figure 6 and Supplementary Figure S4C).
Even though miR-1225 and miR-1228 abundance was not
affected by the absence of Argonaute-2 in the knockout
cell lines (Figure 3C), they do associate with Ago2 when
both are present (Figure 7 and Supplementary Figure S4D
and E) suggesting that simtronic miRNAs in the Ago2
 / 
cells sort into Agos-1,3 and 4, which can compensate for
the lack of Ago2.
One implication of our results is that, in certain situ-
ations, splicing and miRNA biogenesis may be in compe-
tition with one another. Competition between the splicing
of pre-mRNA and the production of the miRNA would
impact not only miRNA target gene expression, but also
miRNA host gene expression. The generation of simtrons,
by virtue of their intron-spanning location and processing
pathway, could have an effect on the expression of the
mRNA from which it is removed. Although excision of
miRNAs from introns has been shown to be compatible
with splicing of the intron, yielding both a pre-miRNA
and spliced mRNA, with little if any impact on expression
of either RNA (72,73), these studies examined miRNAs
which are housed in larger introns and spatially removed
from the essential 50 splice site, 30 splice site, branchpoint
sequence and polypyrimidine tracts. Simtrons, on the
other hand, encompass and excise all of these splice site
sequences during processing. Thus, simtron biogenesis and
splicing would appear to be mutually exclusive if splicing
does not occur ﬁrst (Figure 8).
Considering that many small RNAs are processed from
the introns and non-coding sequences of pre-mRNA tran-
scripts, a mechanism by which excision and expression of
these RNAs is linked to mRNA expression is important to
consider when investigating such phenomenon as genetic
modiﬁers to disease. For example, PKD1, the host gene
for miR-1225, is the most frequently mutated gene in
autosomal dominant polycystic kidney disease (85% of
cases) (74,75). Polycystic kidney disease, for reasons that
are not clear, has variable disease severity (74,75). One
intriguing possibility is that miR-1225 is a disease
modiﬁer that, depending on the type of mutation in the
gene, could inﬂuence the penetrance of the disease (74).
Furthermore, mutations found only within the simtron
containing intron are associated with disease (76–78).
Likewise, miR-1228 is housed within the LRP1 gene,
which has diverse functions in the cell and has been
implicated to play a role in atherosclerosis and
Alzheimer’s disease (79). The idea that two separate bio-
genesis pathways (mirtronic and simtronic) can generate
the same miRNA may indicate the importance of these
miRNAs in the maintenance of homeostasis.
The discovery of the simtron biogenesis pathway dem-
onstrates the complexity of RNA processing and uncovers
another mechanism by which small non-coding RNAs can
be produced from an RNA transcript. Our results also
caution against the assumption of a biogenesis mechanism
based on sequence, location and predicted structure alone.
It is possible that other predicted mirtrons are not
splicing-dependent, but are instead processed by the
simtron pathway.
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